VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, January 7, 2026
Stock Comparison
Interactive Brokers Group, Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Interactive Brokers Group, Inc.
IBKR · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Interactive Brokers Group, Inc.'s moat claims, evidence, and risks.
View IBKR analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 60 / 100 for Interactive Brokers Group, Inc.).
- Segment focus: Interactive Brokers Group, Inc. has 1 segment (100% in Electronic brokerage); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Weak vs Moderate.
- Moat breadth: Interactive Brokers Group, Inc. has 4 moat types across 4 domains; Sanofi has 5 across 3.
Primary market context
Interactive Brokers Group, Inc.
Electronic brokerage
Multi-asset electronic brokerage, clearing, custody, and financing (self-directed and institutional)
Global
Individual investors and institutional clients (e.g., hedge funds, advisors, proprietary trading firms, introducing brokers)
Broker-dealer / clearing broker / platform operator
100%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Interactive Brokers Group, Inc. strengths
Sanofi strengths
Segment mix
Interactive Brokers Group, Inc. segments
Full profile >Electronic brokerage
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.